
HARTFORD, CT — Patients, family members, and advocates made passionate pleas to add opioid use disorder and withdrawal to the list of conditions eligible for medical marijuana in Connecticut, but they left Monday’s meeting disappointed.
The Board of Physicians tabled the condition following Monday’s public hearing. They said they want to seek further input from the addiction and mental health community before adding it to the list of conditions approved to purchase the drug.
“Our opioid overdose rates are rising greatly every day on an hourly basis, so if we have any potential option to reduce those risks for people and their families then we should look at it more wholeheartedly than they were today,” Christina Capitan, a patient liaison and community advocate for Prime Wellness of Connecticut, said.
Capitan’s company is one of nine distributors of medical marijuana.
Members of the community spoke about their personal experiences with opioid addiction and how cannabis extracts improved their pain, allowing them to embark on a path to recovery. Some pharmacists also suggested that the addition of the condition would enable data collection.
“My only goal was to treat my Crohn’s, so I could stay ahead of the pain and discomfort. ” Marc Huberman said. “The cannabis extracts kept my symptoms in control and during that whole time I was a functional member of society. It has really been an amazing benefit.”
A handful of people objected to the inclusion of opioid use disorder and withdrawal as an approved condition. They suggested exercise and diet would be just as helpful to the population.
The other three conditions also being considered Monday did not receive the same amount of advocacy from Connecticut residents. One person testified on Progressive Degenerative Disc Disease of the Spine, while nobody testified for in favor of adding albinism and Osteogenesis Imperfecta.
Despite the lack of testimony, the Board of Physicians voted to recommend osteogenesis imperfecta for both adults and patients under 18. Albinism (Nystagmus) was not recommended and Progressive Degenerative Disc Disease of the Spine was tabled until a future meeting that will be scheduled to further discuss on how best to define this condition.
Support authentic, locally owned and operated public service journalism!
There are currently 22 conditions that may qualify adults for Connecticut’s Medical Marijuana Program, and 6 conditions for patients under 18. There are currently 23,889 medical marijuana patients in the state, and 834 physicians registered with the program.
There are four growers and nine dispensaries.
More Health Care News & Analysis
Medical Examining Board Fines Doctor $10,000
The state Medical Examining Board on Tuesday fined an Oxford doctor $10,000 for fraudulently using another doctor’s name and Drug Enforcement Agency registration number to prescribe controlled substances to a family member.
Keep reading
Clinical Trials With Immunotherapy Drugs Are Source Of Hope And Challenges In Treating Aggressive Breast Cancer
Joshalyn Mills of Branford and Nancy Witz of Kensington had the best possible results after being treated in clinical trials with immunotherapy drugs for aggressive breast cancer: Their tumors were eliminated. But while there are dramatic successes with immunotherapy drugs, there are also many failures, and researchers are trying to find out why in hopes…
Keep reading
Coalition of Health Insurers Questions Viability of Connecticut Partnership Plan
Members of Connecticut’s Health Care Future, a coalition of health insurers, hospitals, and businesses, are questioning whether Connecticut lawmakers have done enough this year to protect teachers and municipal employees from increases in health insurance premiums. “Despite repeated bailouts from taxpayers, the Connecticut Partnership Plan continues to be a fiscal Titanic that demonstrates why government-controlled health…
Keep reading
AG’s Tackle Mental Health Parity
Attorneys General in Connecticut and Rhode Island threw their support Monday behind a coalition of mental health advocacy groups asking a federal appeals court to revisit a recent ruling giving insurance companies more flexibility to deny mental health claims.
Keep reading
Budget Green Lights Psychedelic Therapies
Buried in the budget Gov. Ned Lamont signed this week is a provision that would create a pilot program to allow Connecticut to be the first-in-the-nation to study the impact of psychedelic drugs like psilocybin and MDMA on patients with depression and PTSD. The budget now creates a pilot program within the Department of Mental…
Keep reading
Officials Highlight Effort To Boost Mental Health Services For Kids
At a Hartford-based community provider Wednesday, Gov. Ned Lamont and a handful of his agency commissioners highlighted the expected impact of more than $100 million in recently passed funding aimed at increasing behavioral health services for Connecticut children. The governor appeared at The Village for Families and Children, a recipient of new state funding included…
Keep reading